How Much Does Inuspheresis Cost?

Published on December 7, 2025 | Prices Last Reviewed for Freshness: January 2026
Written by Alec Pow - Economic & Pricing Investigator | Medical Review by Sarah Nguyen, MD

Educational content; not medical advice. Prices are typical estimates and may exclude insurance benefits; confirm with a licensed clinician and your insurer.

People who search for INUSpheresis are usually already dealing with complex, long lasting illness. Many live with long COVID, ME/CFS, chronic infections or autoimmune problems and encounter INUSpheresis on clinic websites or in patient forums when standard care has not delivered relief. For U.S. readers, the central question is often whether the price, overseas travel and time away from work can be justified for a procedure that is still considered experimental in most health systems and is rarely available as a routine option in American hospitals.

INUSpheresis is a branded form of therapeutic apheresis. Blood is circulated through an external machine, inflammatory components are selectively filtered from the plasma and the treated blood is returned to the body. Clinics market it as an intensive detoxification or immune reset treatment rather than a mainstream hospital procedure, which is why it is mostly offered in private centers rather than public hospitals. As of 2025, branded INUSpheresis programs are concentrated in Europe, so Americans usually encounter it as a medical-tourism option rather than something their local hospital offers.

The financial side of that offer is significant. Reports collected from European clinics suggest that a short INUSpheresis course commonly costs between about €9,500 and €18,000, roughly $10,000–$20,000 at late 2024 exchange rates, before adding flights, hotel stays and follow up care. At the same time, the global apheresis market is growing quickly, which shows how these filtration treatments are turning into an important revenue stream for device makers and private facilities. Understanding how those session prices are built, how they vary by region and what hidden expenses appear around the procedure helps patients and families in the U.S. and elsewhere decide whether this path fits their medical and financial reality.

Article Highlights

• A short INUSpheresis course in Europe typically costs between about €9,500 and €18,000 (roughly $10,000–$20,000), before adding travel and follow up care.
• Some clinics publish per session prices around €2,500–€3,500, with supportive infusions and diagnostics pushing the course total close to €10,000 or more.
• Hidden costs such as flights, hotels, extra tests and new prescriptions can add another €1,000–€3,000 (about $1,100–$3,300) to the overall spend.
• Mainstream therapeutic plasma exchange and other apheresis techniques may be partly or fully reimbursed when used for recognised indications, which makes them financially less risky than self funded INUSpheresis.
• Location, equipment, case complexity and insurance recognition are the main factors that drive inuspheresis cost up or down.
• Patients who compare regions, negotiate packages, push for partial insurance support and manage travel costs tightly have the best chance of keeping the bill within their budget, especially when converting euro or pound charges into U.S. dollars.

How Much Does Inuspheresis Cost?

Because INUSpheresis is offered by a small number of private centers, price information mainly comes from clinic adverts and patient reports rather than transparent national fee schedules. A widely shared discussion on a chronic illness blog gathered quotes from several European providers and found that a typical two session course in Cyprus cost about €9,500 (around $10,000–$11,000), a similar package in Germany was around €13,000 (roughly $14,000), Switzerland averaged close to €15,000 (around $16,000–$17,000), and a center in South Germany, in the Bavarian spa town of Bad Aibling, charged about €18,000 (close to $19,000–$20,000) for two treatments.

Per session pricing can also be found in some clinic lists. One apheresis center in Cyprus quotes €2,690 (roughly $2,900–$3,000) per INUSpheresis session and recommends three treatments for many long COVID patients, while also offering extra vitamin and antioxidant infusions at additional cost. A London private clinic mentioned in patient reports charges about £3,000 per session, which translates to roughly $3,700–$3,900 for U.S. visitors before card fees and exchange-rate spread.

Converted into dollars, that means a single short INUSpheresis course often falls somewhere between roughly $10,000 and close to $20,000 just for the procedure itself. Those figures sit on top of ongoing medical bills and come out of pocket for many patients because national insurers or private health plans often treat the therapy as non standard. For U.S. households used to seeing bills in dollars, the key is to budget both for the euro- or pound-denominated clinic fee and for what their bank or card issuer adds on top in currency conversion charges.

Real-Life Cost Examples

Patient stories highlight how the numbers play out in daily life. One person who travelled to Germany for two INUSpheresis sessions described marked, but temporary, symptom relief and summarised the financial hit as “a lot” even before counting flights and accommodation. If the course was priced near the €13,000 (about $14,000) level that German centers often quote, a couple travelling from North America would probably see a total trip budget close to €16,000–€17,000 (roughly $17,000–$19,000) once airfare, local transport and a week in a hotel are added, a pattern echoed in long COVID apheresis write ups on sites like Health Rising.

Another patient compared offers from several European providers. On paper, Cyprus looked clearly cheaper at about €9,500 (around $10,000–$11,000) for two treatments. After building a realistic budget, including travel from northern Europe or the United States, extra laboratory work requested by the clinic and one extra hotel night for rest after the second session, the total cost came out close to a German package that initially appeared more expensive. The lesson was simple. The headline clinic fee can be misleading if the travel and logistics bill is not included in the first estimate, especially for intercontinental trips.

Local residents see a different pattern. For someone living in Cyprus, that same clinic’s structure of three sessions at €2,690 each, plus an optional high dose vitamin C infusion at €180 and a multivitamin infusion at €80, can bring the medical bill to roughly €9,810 (about $10,800) with no need to purchase airline tickets. Another person in London who books two sessions at £3,000 each might face a similar figure in pounds when consultation fees, lab tests and medication adjustments are added. In both cases, the shape of the cost is similar, even if the mix of travel and clinic charges differs.

There are also quieter follow on expenses. Some patients pay for extra blood tests at home because their regular doctor wants new safety data. Others need new prescriptions to manage temporary changes in blood pressure or clotting risk, or pay for extra nights in a hotel after post procedure fatigue makes same day travel difficult. These add another layer of medical expense around a therapy that is already priced at the upper end of most household budgets, particularly for U.S. families converting euro invoices into dollars on every trip.

Cost Breakdown

Every INUSpheresis bill is made up of several components. At the core lies the procedure fee. This covers the use of an apheresis machine, the single use tubing sets and filters, anticoagulant solutions, monitoring equipment, trained nurses and the supervising physician. In European clinics that publish figures, this basic charge usually sits somewhere between about €2,500 and €3,500 per session (roughly $2,700–$3,800), with the variation driven by staffing costs and local price levels, in line with how standard therapeutic apheresis is described in overviews such as News-Medical’s guide to apheresis.

Layered on top are consultation and diagnostic fees. New patients almost always need at least one detailed assessment visit in which their history, medications and previous test results are reviewed. They also require laboratory panels for kidney and liver function, inflammation markers and clotting parameters. In a private setting, that workup can easily cost between €500 and €1,000 (about $550–$1,100). If cardiology or immunology input is required, additional specialist fees appear on the invoice.

Supportive infusions form another cost category. Many INUSpheresis programs link the filtration sessions with vitamin drips or nutrient cocktails. The Cypriot clinic mentioned earlier offers high dose vitamin C at about €180 (around $200) per infusion and a multivitamin mix at around €80 (roughly $90). When such infusions are scheduled on each treatment day and sometimes on the days in between, the total for these extras can reach several hundred or even a few thousand euros over a full course.

Facility overhead is also priced into the treatment. A center in a high rent city or popular spa town must charge more to cover wages, utilities and property costs than a unit in a smaller, less expensive location. This difference shows up clearly when a two treatment course in Cyprus is priced at €9,500, while a similar course in Bad Aibling reaches around €18,000. The technology may be similar, yet the local economy and market positioning of the clinic drive a large part of the gap for any patient, including those arriving from the United States.

Beyond the clinic, there are hidden costs that belong in any realistic estimate. International travel requires plane tickets, airport transfers, hotel bookings, meals and sometimes a support person’s lost earnings. Aftercare often includes follow up visits with regular doctors, repeat laboratory testing and prescription changes. Those extra items can add another €1,000 to €3,000 (roughly $1,100–$3,300) to the overall spend over several months. The bills add up fast, and U.S. households rarely see any of this reimbursed when treatment happens overseas.

Factors Influencing the Cost

Provider location is one of the strongest drivers of inuspheresis cost. Cyprus and some eastern European centers can offer lower per session prices because wages and overhead are lower, and they often position themselves as regional hubs for medical travellers. Germany and Switzerland, by contrast, have higher staff costs and higher living costs, which push full course prices into the €15,000 to €18,000 (roughly $16,000–$20,000) band for some clinics. For U.S. patients, the choice is less about picking between nearby cities and more about deciding which European country’s pricing, travel and visa rules make most sense.

Equipment and consumable choices also affect pricing. INUSpheresis uses multi stage filtration cartridges and advanced apheresis machines supplied by global manufacturers. Single use columns, tubing sets and sterile solutions are consumed at every session. When a protocol calls for two or three treatments in a single trip, consumables alone contribute a noticeable slice of the final bill, and clinics pass these costs directly on to patients. The wider apheresis equipment market is growing quickly—industry analyses from firms such as Grand View Research project steady annual growth—which supports premium pricing for highly specialised systems.

Clinical complexity matters as well. Patients with long standing illness, cardiovascular risk or clotting issues may need longer treatments, more frequent monitoring and extended observation after each session. Providers sometimes use this as a reason to steer such patients toward inpatient care or to charge higher per session fees. People who travel from far away may be advised to compress sessions into a short time window, which keeps travel costs down but also increases the total clinic bill for that period.

Also read our articles on the cost of MTHFR Gene Mutation tests, Galleri blood tests, or double lung transplants.

Another factor is how health systems classify the therapy. Mainstream therapeutic plasma exchange appears in national and professional guidelines for several autoimmune and blood related conditions. INUSpheresis, by contrast, is not yet widely listed as a standard indication based procedure, and it is not a named option in typical U.S. coverage policies. In practice, that means many insurers treat it as an experimental or elective intervention and decline to reimburse it, which leaves patients paying out of pocket even in countries with otherwise strong insurance coverage.

Broader market dynamics complete the picture. Analysts estimate that the global apheresis sector is growing at a healthy pace, driven by increased demand for plasma components, chronic disease treatments and advanced apheresis devices. This growth supports the rollout of new machines and centers. It also allows providers to maintain premium pricing, since they can frame INUSpheresis as a scarce, high technology intervention delivered by a small number of specialist teams—and as a once in a lifetime opportunity for overseas visitors.

Alternative Products or Services

People who consider INUSpheresis rarely view it in isolation. The most closely related option is standard therapeutic plasma exchange. This procedure, which removes plasma and replaces it with donor plasma or albumin, is offered in many university and regional hospitals for recognised indications such as myasthenia gravis, thrombotic microangiopathies and some antibody mediated kidney diseases. In the United States, it is performed in hospital settings and described in consumer facing materials such as therapeutic plasma exchange guides. Because it is embedded in guidelines, it is more often reimbursed or subsidised by insurers, which makes out of pocket costs much lower for eligible patients than for self funded INUSpheresis.

Other apheresis variants include immunoadsorption and heparin mediated LDL precipitation, sometimes known as HELP apheresis. These techniques target specific blood components and are offered in several European centers for cardiovascular risk reduction or autoimmune conditions. Where they are used within established protocols, national health systems or private plans may cover some or all of the cost, especially in Germany. For patients who meet the indication criteria, these alternatives can offer a more predictable financial path than flying abroad for INUSpheresis.

Drug based strategies also sit in the comparison set. For long COVID and ME/CFS, they include graded pharmacologic approaches that target blood pressure instability, mast cell activation, clotting abnormalities or viral persistence. For autoimmune disease, they include steroids, conventional immunosuppressants and biologic agents. Some of these medicines are expensive, yet they are often at least partly reimbursed, and the cost is spread over months and years rather than concentrated in one large episode.

A final group of alternatives is non procedural and focuses on building capacity rather than filtering blood. Examples include autonomic rehabilitation programs, pacing and activity management coaching, targeted physical therapy and psychological support for living with chronic illness. These options do not promise a dramatic short term effect, yet they protect household budgets and avoid the risks and costs of international medical travel. For many patients, they represent a more sustainable use of limited financial resources than a single high cost experimental course.

Ways to Spend Less

People who still want to pursue INUSpheresis despite the high prices often look for practical ways to lower the bill. One straightforward approach is regional comparison. The price gap between Cyprus at about €9,500 (around $10,000–$11,000) for a course and South Germany at around €18,000 (roughly $19,000–$20,000) shows that simply choosing a lower cost country can cut the headline figure nearly in half, even after paying for flights from many parts of Europe or North America.

Another tool is careful negotiation of the treatment package. Clinics vary in how they structure their quotes. Some provide a single figure that includes consultations, laboratory tests, the procedure itself and supportive infusions. Others itemise every part. Patients who ask for a written breakdown can identify optional elements such as extra vitamin drips, non essential imaging or additional wellness services. Dropping those can easily save €1,000 to €2,000 without touching the core filtration sessions. Small line items add up over a two week trip, and research on travel for chronic illness care, such as analyses of barriers and costs for IBD patients in papers indexed on ResearchGate, shows similar patterns.

Insurance advocacy can also reduce out of pocket cost. Even when a policy does not list INUSpheresis as a covered benefit, some funds will consider partial reimbursement when the procedure is used in severe autoimmune disease and is clearly documented as a last resort. That process usually requires letters from specialists, detailed medical records and persistence with appeals. Success is never guaranteed. When it works, though, even a single payment of €3,000 or €4,000 (roughly $3,300–$4,400) makes a noticeable difference to the household budget.

Non medical expenses are easier to control. People can travel in low season, book flights and hotels early, choose apartments with kitchen facilities instead of full service hotels, share rooms with a support person and use public transport rather than taxis where safe. Some patients coordinate with peers so that two families travel at the same time, share airport rides and sometimes secure small group discounts on accommodation or local services. One long bill arrives at the end. Thoughtful planning spreads that burden and trims the total, especially when the starting point is a five figure euro invoice.

Answers to Common Questions

Is INUSpheresis usually covered by insurance?

Most public and private insurers do not list INUSpheresis as a standard covered treatment, especially when it is used for long COVID or ME/CFS. Some patients with clearly defined autoimmune disease report partial reimbursement after individual review, but many people pay the full course price themselves, particularly when treatment is done abroad.

How many INUSpheresis sessions are common in one course?

Clinic protocols differ, yet two sessions with one rest day between them is a frequent pattern. Some centers recommend three sessions for long COVID. When per treatment fees sit around €2,500–€3,500 (roughly $2,700–$3,800), a two or three session course quickly reaches five figures.

How does INUSpheresis cost compare to standard plasma exchange?

Standard therapeutic plasma exchange is usually delivered in hospitals under guideline based indications. Even though the procedure itself is expensive, insurers more often contribute, so patient copays or deductibles are usually lower than the full self funded cost of an INUSpheresis course in a private clinic, especially for U.S. patients using in network hospitals.

Are there cheaper alternatives that still offer potential benefit?

Yes. For many conditions, there are drug based regimens, rehabilitation programs, pacing and autonomic regulation strategies that carry lower direct cost, especially when provided inside public or insured systems. They do not offer the same rapid, high intensity experience, but they are friendlier to long term household budgets.

What is the main hidden cost people forget to budget for?

Travel related expense is often underestimated. Flights, hotels, meals, local transport and lost income for patients and companions can add several thousand euros or dollars to the medical bill. Building a full trip budget before committing to treatment helps avoid surprise debt later, particularly for families travelling from the United States to European INUSpheresis centers.